Biotinyl Human IGF-I

$1,645.00

Biotinyl Human Insulin-like Growth Factor-I (biotinyl IGF-I) is prepared by labeling the primary amines of IGF-I with Sulfo-NHS-Biotin, resulting in a mixture of biotinylated species, with di-biotinyl IGF-I being predominant. A molecular spacer is incorporated during the biotinylation process to reduce steric hindrance and facilitate efficient binding to avidin or streptavidin.

This reagent is intended for research use only and is not suitable for diagnostic or therapeutic purposes.

Biotinyl human insulin-like growth factor-I (biotinyl IGF-I) is made by reacting human IGF-I with Sulfo-NHS-Biotin reagent to label the primary amines of the IGF-I molecule. A mixture of biotinylated forms are produced, the major species being di-biotinyl IGF-I. Biotinyl IGF-I has been prepared with a spacer to minimize steric hindrance during subsequent avidin binding.

This product is manufactured in Australia by GroPep Bioreagents.

Size	500 µg





Source Species	Recombinant

Expression System	Ecoli









Storage	2-8°C
Alternative Names	Biotinyl Human Insulin-like Growth Factor-I, biotinyl IGF-I

Biotinyl Human IGF-I

Product Citations